This year, claims have been filed by patients and their family members who say the use of blood thinner Xarelto has led to serious, irreversible internal bleeding and death. The drug currently has no antidote for internal bleeding side effects, and claimants argue that the drug’s manufacturer, Johnson & Johnson, did not publicize such risks.
In November 2012, the U.S. Food and Drug Administration (FDA) approved Xarelto (rivaroxaban), a blood thinner used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Initially, Xarelto was the first and only oral anticoagulant approved to treat DVT and PE without the need for injections or routine blood monitoring.
Contrary to the belief that the blood thinner Xarelto would help prevent life-threatening conditions like stroke and heart problems, many individuals are now facing health issues that are just as debilitating – if not more debilitating – than the diseases they were trying to prevent.
Specifically, the blood-thinner has been associated with:
- Rectal bleeding
- Intestinal bleeding
- Abdominal bleeding
- Hemorrhaging in the brain
If you are taking Xarelto, talk to your doctor about your risk for any of the above life-threatening side effects. Do not stop taking any medication before seeking advice from a physician. If you have experienced any of the above side effects, see a doctor immediately.
The pharmaceutical lawyers of Simmons Hanly Conroy are dedicated to helping individuals injured by dangerous drugs like Xarelto to seek the justice they deserve.